Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: A double-blind, randomised placebo-controlled, phase 3 trial

The Lancet Oncology

Volumn 16, Issue 15, 2015, Pages 1463-1472

  Chow, Edward ^a   Meyer, Ralph M ^b   Ding, Keyue ^c   Nabid, Abdenour ^d   Chabot, Pierre ^e   Wong, Philip ^f   Ahmed, Shahida ^g   Kuk, Joda ^h   Dar, A Rashid ⁱ   Mahmud, Aamer ^j   Fairchild, Alysa ^k   Wilson, Carolyn F ^c   Wu, Jackson S Y ^l   Dennis, Kristopher ^m   Brundage, Michael ⁿ   DeAngelis, Carlo ^a   Wong, Rebecca K S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^e MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g CANCERCARE MANITOBA   (Canada)

^h Grand River Regional Cancer Centre   (Canada)

ⁱ LONDON REGIONAL CANCER PROGRAM   (Canada)

^j KINGSTON GENERAL HOSPITAL   (Canada)

^k CROSS CANCER INSTITUTE   (Canada)

^l UNIVERSITY OF CALGARY   (Canada)

^m OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁿ QUEEN S UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PLACEBO; GLUCOCORTICOID;

ADULT; AGED; ANALGESIA; ANOREXIA; ARTICLE; BLOATING; BONE METASTASIS; BONE PAIN; CANCER PALLIATIVE THERAPY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HUMAN; HYPERGLYCEMIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; RADIATION INDUCED PAIN; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; ADVERSE EFFECTS; BONE NEOPLASMS; CANADA; CLINICAL TRIAL; PAIN; PALLIATIVE THERAPY; SECONDARY;

AGED; BONE NEOPLASMS; CANADA; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PAIN; PALLIATIVE CARE; RADIOTHERAPY;

EID: 84961061692     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00199-0     Document Type: Article

References (31)

1. Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 79:965-976.
2. Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S Update on the systemic review in palliative radiotherapy trials for bone metastases. Clin Oncol 2012, 24:112-124.
3. Loblaw DA, Wu JS, Kirkbride P, et al. Pain flare in patients with bone metastases after palliative radiotherapy-a nested randomized control trial. Support Care Cancer 2007, 15:451-455.
4. Hird A, Chow E, Zhang L, et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three Canadian cancer centers. Int J Radiat Oncol Biol Phys 2009, 75:193-197.
5. Chow E, Ling A, Davis L, Panzarella T, Danjoux C Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases. Radiother Oncol 2005, 75:64-69.
6. Gomez-Iturriaga A, Cacicedo J, Navarro A, et al. Incidence of pain flare following palliative radiation therapy for symptomatic bone metastases: a multicenter prospective observational study. Int J Radiat Oncol Biol Phys 2014, 90:S81.
7. Kirkbride P, Aslanidis J Single fraction radiation therapy for bone metastases-a pilot study using a dose of 12 Gy. Clin Invest Med 1996, 19:S87.
8. Roos DE, Turner SL, O'Brien PC, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005, 75:54-63.
9. Foro P, Algara M, Reig A, et al. Randomized prospective trial comparing three schedules of palliative radiotherapy: preliminary results. Oncologia 1998, 21:55.
10. Hird A, Wong R, Flynn C, et al. Impact of pain flare on patients treated with palliative radiotherapy for symptomatic bone metastases. J Pain Manage 2009, 2:401-406.
11. Chow E, Loblaw A, Harris K, et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a pilot study. Support Care Cancer 2007, 15:643-647.
12. Barnes PJ How corticosteroids control inflammation: Quintiles Prize Lecture. Br J Pharmacol 2006, 148:245.
13. Holte K, Kehlet H Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 2002, 195:694.
14. Salerno A, Hermann R Efficacy and safety of steroid use for postoperative pain relief: Update and review of the medical literature. J Bone Joint Surg Am 2006, 88:1361.
15. Hird A, Zhang L, Holt T, et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. Clin Oncol 2009, 21:329-335.
16. Groenvold M, Petersen MA, Aaronson NK, et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 2006, 42:55-64.
17. Echteld MA, Onwuteaka-Philipsen B, van der Wal G, et al. EORTC QLQ-C15-PAL: the new standard in assessment of health-related quality of life in advanced cancer?. Palliat Med 2006, 20:1.
18. Chow E, Hird A, Velikova G, et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer 2009, 45:1146-1152.
19. Vardy J, Chiew KS, Galica J, et al. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 2006, 94:1011-1015.
20. Chow E, Wu J, Hoskin P, et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002, 64:275-280. on behalf of the International Bone Metastases Consensus Working Party.
21. Fleiss JL, Tytun A, Unh HK A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 1980, 35:343.
22. Sato T A further look at the Cochran-Mantel-Haenszel risk difference. Controlled Clin Trials 1995, 16:359-361.
23. Osoba D, Bezjak A, Brundage M, et al. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer 2005, 41:280-287.
24. Yousef AA, El-Mashad NM Pre-emptive value of methylprednisolone intravenous infusion in patients with vertebral metastases. A double-blind randomized study. J Pain Symptom Manage 2014, 48:762-769.
25. Olson RA, Tiwana MS, Barnes M, et al. Use of single- versus multiple-fraction palliative radiation therapy for bone metastases: population-based analysis of 16,898 courses in a Canadian province. Int J Radiat Oncol Biol Phys 2014, 89:1092-1099.
26. Ashworth A, Kong W, Chow EL, Mackillop W The fractionation of palliative radiation therapy for bone metastases in Ontario: do guidelines guide practice?. Int J Radiat Oncol Biol Phys 2014, 90:S63-S64.
27. Rutter CE, Yu JB, Wilson LD, Park HS Assessment of national practice for palliative radiation therapy for bone metastases suggests marked underutilization of single-fraction regimens in the United States. Int J Radiat Oncol Biol Phys 2015, 91:548-555.
28. Laugsand TS, Kaasa S, Romundstad P, Johannesen TB, Lund JÅ Radiotherapy for bone metastases: practice in Norway 1997-2007. A national registry-based study. Acta Oncol 2013, 52:1129-1136.
29. Petrushevski AN, Gabriel GS, Hanna TP, Allen S, Allison RW, Barton MB Factors affecting the use of single-fraction radiotherapy for the palliation of bone metastases in Australia. Clin Oncol 2015, 27:205-212.
30. Sturdza A, Millar BA, Bana N, et al. The use and toxicity of steroids in the management of patients with brain metastases. Support Care Cancer 2008, 16:1041-1048.
31. Langley RE, Stephens RJ, Nankivell M, et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?. Clin Oncol 2013, 25:e23-e30.